Cardiff Oncology(DE:XE7C)
€0.58-0.06 (-9.25%)
DE:XE7C
Cardiff Oncology earnings date
€0.58
At close:-0.06 (-9.25%)
Cardiff Oncology (XE7C) Q1 2024 Earnings Report
3 Followers
DE:XE7C Q1 2024 EPS Results
- Actual EPS
- -EUR 0.20
- Consensus EPS
- -EUR 0.22
- Beat/Miss
- Beat by +EUR 0.03
- One Year Ago EPS
- -EUR 0.23
DE:XE7C Q1 2024 Revenue Results
- Actual Revenue
- EUR 185.31K
- Expected Revenue
- EUR 56.04K
- Beat/Miss
- Beat by +EUR 129.26K
- YoY Revenue Growth
- +146.99%
Earnings Announcement Details
- Quarter
- Q1 2024
- Date
- 05/02/2024
- Time
- After Close
- Conference Call
- Thursday, May 2, 2024
DE:XE7C Upcoming Earnings
Cardiff Oncology's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q1 2024 Earnings Call Audio
DE:XE7C Q1 2024 Earnings Call
0:00 / 0:00
Q1 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:XE7C Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.12- | -0.1 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.12-0.11 | -0.15 | 29.41% (+0.05) | |
| Aug 11, 2026 | 2026 (Q2) | -0.11-0.13 | -0.19 | 33.33% (+0.06) | |
| May 14, 2026 | 2026 (Q1) | -0.12-0.16 | -0.18 | 10.00% (+0.02) | |
| Feb 24, 2026 | 2025 (Q4) | -0.17-0.10 | -0.2 | 50.00% (+0.10) | |
| Nov 06, 2025 | 2025 (Q3) | -0.19-0.15 | -0.23 | 32.00% (+0.07) | |
| Jul 29, 2025 | 2025 (Q2) | -0.17-0.19 | -0.24 | 19.23% (+0.05) | |
| May 08, 2025 | 2025 (Q1) | -0.17-0.18 | -0.2 | 9.09% (+0.02) | |
| Feb 27, 2025 | 2024 (Q4) | -0.22-0.20 | -0.19 | -4.76% (-0.01) | |
| Nov 07, 2024 | 2024 (Q3) | -0.24-0.23 | -0.2 | -13.64% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

